<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Pan Afr Med J</journal-id>
      <journal-id journal-id-type="publisher-id">PAMJ</journal-id>
      <journal-title-group>
        <journal-title>The Pan African Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1937-8688</issn>
      <publisher>
        <publisher-name>The African Field Epidemiology Network</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22937184</article-id>
      <article-id pub-id-type="pmc">3428164</article-id>
      <article-id pub-id-type="publisher-id">PAMJ-12-44</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Acute pseudo-septic arthritis following viscosuplementation of the knee</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Idrissi</surname>
            <given-names>Zineb</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
          <xref ref-type="corresp" rid="cor1">&amp;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Benbouazza</surname>
            <given-names>Karima</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fourtassi</surname>
            <given-names>Maryam</given-names>
          </name>
          <xref ref-type="aff" rid="AF0002">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Raissouni</surname>
            <given-names>Hanae</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>El Aadmi</surname>
            <given-names>Meriem</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zanat</surname>
            <given-names>Fatima</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hajjaj-Hassouni</surname>
            <given-names>Najia</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">1</xref>
        </contrib>
      </contrib-group>
      <aff id="AF0001"><label>1</label>Rheumatology Department, El Ayachi Hospital, Mohammed the Vth University, Rabat, Morocco</aff>
      <aff id="AF0002"><label>2</label>Physical medicine and rehabilitation Department, El Ayachi Hospital, Mohammed the Vth University, Rabat, Morocco</aff>
      <author-notes>
        <corresp id="cor1"><label>&amp;</label>Corresponding author: Zineb Idrissi, Rheumatology Department, El Ayachi Hospital, Mohammed the Vth University, Rabat, Morocco</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>23</day>
        <month>6</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2012</year>
      </pub-date>
      <volume>12</volume>
      <elocation-id>44</elocation-id>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>2</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>03</day>
          <month>3</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Zineb Idrissi et al.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>A 70-year-old woman with a history of medial femoro-tibial compartment of knee osteoarthritis was admitted for acute arthritis six days after a second intra-articular injection of Hyaluronic acid. The joint fluid was inflammatory, with no crystals, and laboratory tests showed marked inflammation leading to antibiotic treatment for suspected septic arthritis. The persistent symptoms and negative results of joint fluid and blood cultures led to discontinuation of the antibiotic therapy after 10 days. Anti-inflammatory with rehabilitation therapy of the knee relieved the symptoms, and the patient was discharged home 3 weeks after her admission. Aseptic arthritis induced by repeated Hyaluronic acid injection is the most likely diagnosis. Physicians should be conscious of this extremely severe complication.</p>
      </abstract>
      <kwd-group>
        <kwd>Pseudoseptic arthritis</kwd>
        <kwd>Hyaluronic acid</kwd>
        <kwd>complicaton</kwd>
        <kwd>viscosupplementation</kwd>
        <kwd>knee</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="S0001">
      <title>Introduction</title>
      <p>Intra-articular hyaluronic acid (HA) injection is one of several other treatments available for knee osteoarthritis. It provides both articular cartilage and synovial membrane with visco-elastic protection [<xref ref-type="bibr" rid="CIT0001">1</xref>]. As a therapeutic agent, HA has no pharmacological nor immunological effects but it can improve the rheological properties of the synovial liquid resulting in pain alleviation and joint-mobility improvement [<xref ref-type="bibr" rid="CIT0001">1</xref>, <xref ref-type="bibr" rid="CIT0002">2</xref>]. Very few cases of aseptic arthritis complicating intra-articular injection of HA were described [<xref ref-type="bibr" rid="CIT0003">3</xref>]. We report a new case of pseudo-septic acute mono-arthritis of the knee revealed six days after an intra-articular injection of HA.</p>
    </sec>
    <sec id="S0002">
      <title>Patient and case report</title>
      <p>A 70-year-old woman with medial femoro-tibial gonarthrosis underwent two intra-articular HA injections (Ost&#xE9;nil<sup>&#xAE;</sup>) because of the persistence of pain while walking and restricted ability to walk. Both injections were performed under aseptic conditions. Six days after the second injection, she presented with acute mono-arthritis, major functional impotence and fever. Joint fluid analysis showed 12,000 cells per mm<sup>3</sup> with 83% of neutrophils and 17% of lymphocytes. A knee aspiration was performed to evaluate the possibility of a joint infection. The examination of synovial fluid under phase contrast and polarizing microscope showed no crystals, and culture on standard media was negative. The biological assessment showed an erythrocyte sedimentation rate at 80mm, C Reactive protein at 160mg/l, and white blood cell count was 10,000 elements per mm<sup>3</sup>. In the light of these findings, acute septic arthritis was considered to be the most likely diagnosis, and probabilistic intra-venous antibiotic therapy, with Getamycine 160 mg per day and flucloxacilline 2g every 6 hours, was started. The persistent symptoms and negative results of joint fluid and blood cultures did not plead in favour of a septic origin. In front of this beam of arguments, antibiotic therapy was stopped after 10 days, non-steroidal anti-inflammatory drugs were administered and rehabilitation therapy of the knee was started. The clinical and laboratory test abnormalities were normalized within two weeks.</p>
    </sec>
    <sec sec-type="discussion" id="S0003">
      <title>Discussion</title>
      <p>Viscosupplementation by intra-articular injection of HA seems to be practically risk free [<xref ref-type="bibr" rid="CIT0003">3</xref>&#x2013;<xref ref-type="bibr" rid="CIT0005">5</xref>]. The most common adverse event associated with their use is an inflammatory reaction or a flare at the injection site [<xref ref-type="bibr" rid="CIT0005">5</xref>].The occurrence of non microcrystalline aseptic arthritis after injection of HA was rarely described [<xref ref-type="bibr" rid="CIT0003">3</xref>, <xref ref-type="bibr" rid="CIT0004">4</xref>].</p>
      <p>All the cases occurred after injection of hylane GF-20 (Synvisc<sup>&#xAE;</sup>) which is a polymer of hyaluronate [<xref ref-type="bibr" rid="CIT0003">3</xref>] and only one case with the sodium hyaluronan (Ostenil<sup>&#xAE;</sup>) [<xref ref-type="bibr" rid="CIT0005">5</xref>]. The delay of appearance of arthritis is generally short, lower than 72 hours [<xref ref-type="bibr" rid="CIT0005">5</xref>]. The joint fluid is always inflammatory. The evolution is quickly satisfactory thanks to non steroidal anti-inflammatory drugs or corticoids allowing a complete recovery without relapse within a few days to three weeks maximum [<xref ref-type="bibr" rid="CIT0003">3</xref>&#x2013;<xref ref-type="bibr" rid="CIT0005">5</xref>].</p>
      <p>Our case has several particularities. The onset delay was six days versus 72 hours in other reported cases. On the other hand, our patient presented with a severe arthritis mimicking an acute septic arthritis after using (Ostenil<sup>&#xAE;</sup>) which is known to produce no allergenic reactions [<xref ref-type="bibr" rid="CIT0004">4</xref>]. The quickly favourable clinical and biological evolution under only symptomatic treatment allowed correcting the diagnosis. However, at the onset of arthritis after viscosupplementation, infectious complications should always be first and foremost, ruled out by realising a systematic joint aspiration with cytological and bacteriological analysis of the synovial fluid.</p>
      <p>The mechanism of acute arthritis after HA injection is not clearly understood. Several hypotheses have been put forth to explain the physiopathology of these arthritis. The fact that they never occur after the first injection suggests the possibility of immune sensitization phenomenon occurring after HA accumulation [<xref ref-type="bibr" rid="CIT0006">6</xref>]. The role of pro-inflammatory cytokines which could be triggered by some HA degradation products is another hypothesis to be considered [<xref ref-type="bibr" rid="CIT0007">7</xref>]. It should be noted that HA interacts with its receptor CD44, which is involved in leucocytes migration and recruitment during inflammation. Moreover, CD44 is over expressed in osteoarthritis [<xref ref-type="bibr" rid="CIT0009">9</xref>]. Finally, it is also possible that this arthritis was caused by some particles not removed during the purification of this product.</p>
    </sec>
    <sec sec-type="conclusion" id="S0004">
      <title>Conclusion</title>
      <p>In our case, the severity of clinical presentation, mimicking septic arthritis and the most likely accountability of HA deserve to be reported. We think that both doctors and patients should be aware of this uncommon but sometimes confusing side effect of viscosuplementation with hyaluronic acid.</p>
    </sec>
  </body>
  <back>
    <sec id="S0005">
      <title>Competing interests</title>
      <p>The authors declare no competing interests.</p>
    </sec>
    <sec id="S0006">
      <title>Authors&#x2019; contributions</title>
      <p>All the authors have contributed to the manuscript and have read and approve the final version.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="CIT0001">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neustadt</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Long-term efficacy and safety of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee</article-title>
          <source>Clin Exp Rheumatol</source>
          <year>2003</year>
          <season>May-Jun</season>
          <volume>21</volume>
          <issue>3</issue>
          <fpage>307</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="pmid">12846048</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0002">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Balazs</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Denlinger</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Viscosupplementation: a new concept in the treatment of osteoarthritis</article-title>
          <source>J Rheumatol Suppl</source>
          <year>1993</year>
          <month>8</month>
          <volume>39</volume>
          <fpage>3</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">8410881</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0003">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leopold</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Warme</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Pettis</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Shott</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Increased frequency of acute local reaction to intra-articular hylan GF-20 (synvisc) in patients receiving more than one course of treatment</article-title>
          <source>J Bone Joint Surg Am</source>
          <year>2002</year>
          <month>9</month>
          <volume>84-A</volume>
          <issue>9</issue>
          <fpage>1619</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="pmid">12208919</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0004">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Puttick</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Wade</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Chalmers</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Connell</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Rangno</surname>
              <given-names>KK</given-names>
            </name>
          </person-group>
          <article-title>Acute local reactions after intraarticular hylan for osteoarthritis of the knee</article-title>
          <source>J Rheumatol</source>
          <year>1995</year>
          <month>7</month>
          <volume>22</volume>
          <issue>7</issue>
          <fpage>1311</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">7562764</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0005">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roos</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Epaulard</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Juvin</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pavese</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Brion</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Acute pseudoseptic arthritis after intraarticular sodium hyaluronan</article-title>
          <source>Joint Bone Spine</source>
          <year>2004</year>
          <month>7</month>
          <volume>71</volume>
          <issue>4</issue>
          <fpage>352</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">15288866</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0006">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bernardeau</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bucki</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Liot&#xE9;</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Acute arthritis after intra-articular hyaluronate injection: onset of effusions without crystal</article-title>
          <source>Ann Rheum Dis</source>
          <year>2001</year>
          <month>5</month>
          <volume>60</volume>
          <issue>5</issue>
          <fpage>518</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">11302877</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0007">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pullman-Mooar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mooar</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sieck</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Clayburne</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Schumacher</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>Are there distinctive inflammatory flares after hylan g-f 20 intraarticular injections?</article-title>
          <source>J Rheumatol</source>
          <year>2002</year>
          <month>12</month>
          <volume>29</volume>
          <issue>12</issue>
          <fpage>2611</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">12465161</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0008">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kurosaka</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Takagi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Koshino</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Effects of hyaluronate on CD44 expression of infiltrating cells in exudate of rat air pouch, induced by sensitization with lipopolysaccharide</article-title>
          <source>J Rheumatol</source>
          <year>1999</year>
          <month>10</month>
          <volume>26</volume>
          <issue>10</issue>
          <fpage>2186</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">10529137</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0009">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johnson</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Haines</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Harlow</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>AE</given-names>
            </name>
          </person-group>
          <article-title>Adhesion molecule expression in human synovial tissue</article-title>
          <source>Arthritis Rheum</source>
          <year>1993</year>
          <month>2</month>
          <volume>36</volume>
          <issue>2</issue>
          <fpage>137</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="pmid">7679271</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
